GLAZER CAPITAL, LLC

CIK 0001076809 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-17 · Open the SEC source

GLAZER CAPITAL, LLC reported 562 positions worth $4.1M as of June 30, 2026 (13F filed August 17, 2026). Largest holding: JANUS HENDERSON GROUP PLC (8.0%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$4.1M
2026 Q2
Positions
562
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
38.6%
Est. Net Flow (Q)
2026 Q2
10 / 562 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1G4474Y214JANUS HENDERSON GROUP PLCSH$324.2K7.97%6,234,419
2670703107NUVALENT INCSH$218.6K5.38%1,769,665
303770N101APOGEE THERAPEUTICS INCSH$217.8K5.36%1,641,042
4BLD*TOPBUILD CORSH$209.8K5.16%492,249
581619Q105SELECT MED HLDGS CORPSH$177.3K4.36%10,744,069
614888U101CATALYST PHARMACEUTICALS INCSH$113.2K2.79%3,602,865
7HBMHUDBAY MINERALS INCSH$83.8K2.06%3,550,164
8DBRGDIGITALBRIDGE GROUP INCSH$77.7K1.91%4,927,041
916115Q308CHART INDS INCSH$74.8K1.84%357,757
10CZRCAESARS ENTERTAINMENT INC NESH$72.8K1.79%2,412,764

The free plan shows the top 10 positions. The remaining 552 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does GLAZER CAPITAL, LLC hold as of Q2 2026?

GLAZER CAPITAL, LLC reported 562 positions worth $4.1M in its Q2 2026 13F filing. Largest positions: JANUS HENDERSON GROUP PLC (8.0%), NUVALENT INC (5.4%), APOGEE THERAPEUTICS INC (5.4%), BLD* (5.2%) and SELECT MED HLDGS CORP (4.4%).

What did GLAZER CAPITAL, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did GLAZER CAPITAL, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.